Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis

BACKGROUND: Due to the acquired drug resistance, the potency of cisplatin-based chemotherapy is limited in lung cancer, which is a big obstacle in clinical treatment of lung cancer. Abundant evidence has revealed that circular RNAs (circRNAs) exerted facilitating or suppressive function on the tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhihui, Gong, Qiang, Yu, Yan, Zhu, Jialin, Li, Wencan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958770/
https://www.ncbi.nlm.nih.gov/pubmed/31931771
http://dx.doi.org/10.1186/s12890-019-1035-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958770/
https://www.ncbi.nlm.nih.gov/pubmed/31931771
http://dx.doi.org/10.1186/s12890-019-1035-z

Ejemplares similares